Skip to content
Open access

Development and Temporal Validation of a Multimodal Machine Learning Model for Classification of Recent Flare Activity in Inflammatory Bowel Disease: A Retrospective Cohort Study

2026 · Haydarpasa Numune Training and Research Hospital Medical Journal · 0 citations · 27 references

TL;DR

A multimodal model integrating routinely collected data demonstrated good performance in classifying recent flare-related activity in IBD and outperformed single-modality approaches in a temporally distinct validation cohort.

Abstract

Introduction: The aim of this study was to develop and temporally validate a multimodal machine learning model for classifying clinically relevant flare-related activity during the 90 days preceding the index visit in patients with inflammatory bowel disease (IBD). Methods: This retrospective cohort study included 345 adults with IBD in clinical remission or with mild disease activity who underwent routine ileocolonoscopy at a tertiary referral center between December 2025 and March 2026. Demographic, clinical, laboratory, endoscopic, histopathological, and patient-reported data were extracted from electronic medical records for the 90-day pre-index period. The primary outcome was a composite of treatment intensification due to symptomatic worsening, IBD-related hospitalization, or IBD-related surgery during that period. Least absolute shrink-age and selection operator regression was used for feature selection in a development cohort (n=242). Three algorithms – regularized logistic regression, random forest, and eXtreme Gradient Boosting (XGBoost) – were evaluated in a temporally distinct validation cohort (n=103) using area under the receiver operating characteristic curve (AUROC), calibration metrics, and decision curve analysis. Results: Flare-related activity was identified in 76 of 345 patients (22.0%). In the validation cohort, the multimodal XGBoost model showed the best discriminative performance, with an AUROC of 0.84 (95% confidence interval [CI], 0.77–0.91), sensitivity of 78.0%, specificity of 73.8%, positive predictive value of 55.3%, and negative predictive value of 89.1%. The multi-modal model outperformed unimodal models (clinical-only AUROC 0.66, laboratory-only 0.71, endoscopic-only 0.74, and histology-only 0.69) and a baseline clinical model (AUROC 0.73). Calibration was good (Brier score 0.15), and decision curve analysis demonstrated net benefit across clinically relevant thresholds. Discussion and Conclusion: A multimodal model integrating routinely collected data demonstrated good performance in classifying recent flare-related activity in IBD and outperformed single-modality approaches in a temporally distinct validation cohort. External validation is required before clinical implementation.

Read PDF

Similar papers

Open access Sep 2026

Development and temporal prospective validation of an interpretable machine learning model for identifying depressive symptoms in patients with acute exacerbation of chronic obstructive pulmonary disease

A four-feature interpretable model was developed to identify AECOPD patients with concurrent depressive symptoms during hospitalization and demonstrated satisfactory discriminative performance and may assist early risk stratification.

Xin-Yue Zhou, Yu Chen, Kang Qian et al. · 0 citations
Open access Oct 2026

Multimodal prediction of infliximab initiation within 6 months after initiation of conventional therapy in pediatric Crohn's disease: A multicenter algorithm development and validation study.

OBJECTIVES Early prediction of treatment course in pediatric Crohn's disease (CD) remains limited despite the importance of timely biologic therapy. We developed and externally validated a multimodal model integrating colonoscopy images and clinical data to predict infliximab initiation within 6 months after convention...

Seon Young Kim, S. Hwang, Dongjin Yeo et al. · 0 citations
Sep 2026

Construction and evaluation of a machine-learning-based prediction model for pneumonia in patients with acute leukemia.

An interpretable XGBoost model that accurately predicts pneumonia risk in AL patients based on routine admission data is developed and validated and provides actionable risk stratification to inform preemptive diagnostic and therapeutic strategies.

W. Zhuang, Chen Huang, Xu-Dong Ma et al. · 0 citations
Review Open access Oct 2026

Prediction of incident inflammatory bowel disease from routine electronic health records: development and external validation of a longitudinal machine learning model

Longitudinal machine learning can identify increased IBD risk months to years before diagnosis and may define a population for prospective studies of early IBD biology, and quantify lead time and deployment burden.

G. Önal, A. Ayati, M.-Y. L. Chen et al. · 0 citations
Open access Sep 2026

Clinical heterogeneity mapping and machine learning-based prediction of recurrence in gallstone disease: a retrospective cohort study of 9,939 patients

Background Gallstone disease constitutes a substantial global health burden, characterized by notable clinical heterogeneity and a complex risk of recurrence. However, large-scale studies systematically characterizing this heterogeneity and translating these findings into clinically applicable prediction tools remain l...

Xin Zheng, Yun-Jun Yan, Ce Bian et al. · 0 citations
Open access Sep 2026

Outcomes and Reclassification Patterns in Inflammatory Bowel Disease Unclassified: A Multicenter Study Matched With Ulcerative Colitis From Spanish ENEIDA Registry.

BACKGROUND AND AIM Around 10% of patients with inflammatory bowel disease do not fulfill the diagnostic criteria for Crohn's disease (CD) or ulcerative colitis (UC). These cases are labelled as inflammatory bowel disease unclassified (IBDU). The aim of the study was to compare therapeutic requirements in patients with...

M. González-Vivó, B. C. Senosiain, I. Pérez-Martínez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.